Bausch Health Companies Inc. Stock
Bausch Health Companies Inc. took a tumble today and lost -€0.275 (-4.930%).
Our community identified positive and negative aspects for Bausch Health Companies Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bausch Health Companies Inc. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -4.930% | 40.287% | 30.257% | 11.679% | -8.441% | -32.309% | -73.603% |
| Repligen Corp. | 3.890% | 1.842% | 6.342% | 26.472% | -7.739% | -16.699% | -39.133% |
| Opko Health Inc. | 1.820% | -24.832% | -11.111% | 6.870% | 2.733% | -36.951% | -62.264% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 2.400% | -1.156% | 4.908% | -10.938% | -12.755% | -34.733% | -25.000% |
Comments
Bausch Health Cos (NYSE:BHC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat